Skip to main content

Event Details

Summit Therapeutics Presents at the 44th Annual JP Morgan Healthcare Conference

January 12, 2026 9:45 AM PT
San Francisco, California

*Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA).

© Summit Therapeutics Inc.

Trademarks, Registered or Otherwise, are the property of their respective owner(s).